18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden

• Päätekijät: Ling-Shuang Sheng (Tekijä), Rong Shen (Tekijä), Zi-Xun Yan (Tekijä), Chao Wang (Tekijä), Xin Zheng (Tekijä), Yi-Lun Zhang (Tekijä), Hao-Xu Yang (Tekijä), Wen Wu (Tekijä), Peng-Peng Xu (Tekijä), Shu Cheng (Tekijä), Emmanuel Bachy (Tekijä), Pierre Sesques (Tekijä), Nicolas Jacquet-Francillon (Tekijä), Xu-Feng Jiang (Tekijä), Wei-Li Zhao (Tekijä), Li Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2024-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Chimeric antigen receptor T (CAR-T) cell therapy has greatly improved the prognosis of relapsed and refractory patients with large B-cell lymphoma (LBCL). Early identification and intervention of patients who may respond poorly to CAR-T cell therapy will help to improve the efficacy. Ninety...